HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Abortive poliomyelitis — Clinical Guidelines

Overview

Abortive poliomyelitis, also known as non-paralytic poliomyelitis, refers to an acute illness caused by poliovirus without the development of paralysis. It typically presents with flu-like symptoms and can occur in both vaccinated and unvaccinated individuals, though paralysis is rare 2 11.

Diagnosis

Clinical presentation includes fever, sore throat, headache, vomiting, and generalized muscle pain 2.

Laboratory confirmation involves detecting poliovirus in stool samples or throat swabs 2.

No specific grading system exists for abortive poliomyelitis; diagnosis relies on clinical symptoms and virological testing 2.

Management

Supportive care is primarily recommended, including hydration, pain management, and rest 1 3.

No specific antiviral drugs are universally recommended for abortive poliomyelitis 2.

In severe cases requiring respiratory support, mechanical ventilation may be necessary, as demonstrated in historical contexts 1 3.

Special Populations

Pregnancy: Obstetric complications may correlate with pre-existing clinical disabilities from poliomyelitis; careful monitoring is advised 12.

Pediatrics: Focus on vaccination to prevent both abortive and paralytic forms; OPV and IPV schedules vary by region 2 6.

Elderly: Limited specific data; supportive care principles apply similarly to younger adults 1 3.

Comorbidities: No specific guidelines provided; management should consider underlying conditions requiring additional supportive care 1 3.

Key Recommendations

Implement comprehensive vaccination programs using both inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV) to prevent both wild and vaccine-associated poliomyelitis (Evidence: Strong 2 6).

Provide supportive care including hydration and pain management for patients with abortive poliomyelitis (Evidence: Moderate 1 3).

In cases of respiratory distress, consider mechanical ventilation support, especially in severe presentations (Evidence: Expert opinion 1 3).

Monitor pregnant women with a history of poliomyelitis for potential obstetric complications related to pre-existing disabilities (Evidence: Moderate 12).

Ensure pediatric populations are vaccinated according to regional guidelines to prevent poliomyelitis outbreaks (Evidence: Strong 2 6).

References

1 Mets B. Bjørn Ibsen: intensive care and the conundrum of prolonging death. British journal of anaesthesia 2026. link 2 Ciapponi A, Bardach A, Rey Ares L, Glujovsky D, Cafferata ML, Cesaroni S et al.. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis. The Cochrane database of systematic reviews 2019. link 3 Reisner-Sénélar L. The birth of intensive care medicine: Björn Ibsen's records. Intensive care medicine 2011. link 4 Kalantzis G, Skiadas P, Lascaratos J. Constantin Levaditi (1874-1953): a pioneer in Immunology and Virology. Journal of medical biography 2006. link 5 Trubuhovich RV. Further commentary on Denmark's 1952-53 poliomyelitis epidemic, especially regarding mortality; with a correction. Acta anaesthesiologica Scandinavica 2004. link 6 Wattigney WA, Mootrey GT, Braun MM, Chen RT. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Pediatrics 2001. link 7 Weibel RE, Benor DE. Reporting vaccine-associated paralytic poliomyelitis: concordance between the CDC and the National Vaccine Injury Compensation Program. American journal of public health 1996. link 8 . End of the road for poliomyelitis?. Nature 1995. link 9 Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Archives of pediatrics & adolescent medicine 1994. link 10 Carmichael TR, Gibson IH, Küstner HG. Problems in eradicating poliomyelitis from South Africa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1981. link 11 Gerichter CB, Lasch EE, Sever I, el-Massri M, Skalska P. Paralytic poliomyelitis in the Gaza Strip and West Bank during recent years. Developments in biological standardization 1978. link 12 Daw E, Chandler G. Pregnancy following poliomyelitis. Postgraduate medical journal 1976. link 13 Koinange W, Rogowski JJ, Metselaar D. Poliomyelitis: epidemiology and prophylaxis. 3. Nationwide vaccination campaign with the help of lay volunteers. Bulletin of the World Health Organization 1973. link

Abortive poliomyelitis